Guardian Pharmacy Services, Stock Current Asset
| GRDN Stock | 24.94 0.02 0.08% |
Guardian Pharmacy Services, fundamentals help investors to digest information that contributes to Guardian Pharmacy's financial success or failures. It also enables traders to predict the movement of Guardian Stock. The fundamental analysis module provides a way to measure Guardian Pharmacy's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Guardian Pharmacy stock.
As of the 2nd of December 2024, Non Current Assets Total is likely to grow to about 144.6 M, while Other Current Assets are likely to drop about 11.1 M. Guardian | Current Asset |
Guardian Pharmacy Services, Company Current Asset Analysis
Guardian Pharmacy's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Guardian Current Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for Guardian Pharmacy is extremely important. It helps to project a fair market value of Guardian Stock properly, considering its historical fundamentals such as Current Asset. Since Guardian Pharmacy's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Guardian Pharmacy's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Guardian Pharmacy's interrelated accounts and indicators.
Click cells to compare fundamentals
Guardian Current Asset Historical Pattern
Today, most investors in Guardian Pharmacy Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Guardian Pharmacy's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current asset growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Guardian Pharmacy current asset as a starting point in their analysis.
Guardian Pharmacy Current Asset |
| Timeline |
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
| Competition |
Guardian Total Assets
Total Assets |
|
In accordance with the recently published financial statements, Guardian Pharmacy Services, has a Current Asset of 0.0. This is 100.0% lower than that of the Healthcare sector and about the same as Medical Care Facilities (which currently averages 0.0) industry. The current asset for all United States stocks is 100.0% higher than that of the company.
Guardian Current Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Guardian Pharmacy's direct or indirect competition against its Current Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Guardian Pharmacy could also be used in its relative valuation, which is a method of valuing Guardian Pharmacy by comparing valuation metrics of similar companies.Guardian Pharmacy is currently under evaluation in current asset category among its peers.
Guardian Fundamentals
| Revenue | 1.05 B | ||||
| Net Income | 23.9 M | ||||
| Total Debt | 12.98 M | ||||
| Cash Flow From Operations | 70.82 M | ||||
| Total Asset | 271.17 M | ||||
| Working Capital | (8.41 M) | ||||
| Net Asset | 271.17 M |
About Guardian Pharmacy Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Guardian Pharmacy Services,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Guardian Pharmacy using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Guardian Pharmacy Services, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Guardian Pharmacy
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Guardian Pharmacy position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Guardian Pharmacy will appreciate offsetting losses from the drop in the long position's value.Moving against Guardian Stock
| 0.4 | NIVF | NewGenIvf Group | PairCorr |
| 0.37 | TOIIW | The Oncology Institute | PairCorr |
| 0.31 | TOI | Oncology Institute | PairCorr |
The ability to find closely correlated positions to Guardian Pharmacy could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Guardian Pharmacy when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Guardian Pharmacy - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Guardian Pharmacy Services, to buy it.
The correlation of Guardian Pharmacy is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Guardian Pharmacy moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Guardian Pharmacy moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Guardian Pharmacy can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Guardian Pharmacy Piotroski F Score and Guardian Pharmacy Altman Z Score analysis. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Retail space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardian Pharmacy. If investors know Guardian will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardian Pharmacy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Guardian Pharmacy is measured differently than its book value, which is the value of Guardian that is recorded on the company's balance sheet. Investors also form their own opinion of Guardian Pharmacy's value that differs from its market value or its book value, called intrinsic value, which is Guardian Pharmacy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardian Pharmacy's market value can be influenced by many factors that don't directly affect Guardian Pharmacy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardian Pharmacy's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardian Pharmacy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardian Pharmacy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.